Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board

Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board

Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) is pleased to announce the formation of its Clinical Advisory Board with the appointment of three distinguished, internationally recognized gastroenterologists. The three appointees are: Dr. Francis Chan, Professor of Medicine at The Chinese University of Hong Kong; Dr. Angel Lanas, Professor of Medicine, University of Zaragoza (Spain); and Dr. James Scheiman, Professor of Internal Medicine at the University of Michigan.

Suggested Articles

The EMA and FDA will need traditional clinical trial hurdles removed if governments want the inoculations as quickly as possible.

In this week's EuroBiotech Report, Sitryx inks Lilly deal, Genfit downplays COVID-19 impact on NASH data and Gilead tests remdesivir in U.K.

Amgen and new partner Adaptive Biotechnologies are the latest pharma-biotech duo joining forces against the pandemic.